CAR-T: Why not me?

Dr Senutovitch received her B.Sc. in biochemistryfrom New Mexico State University. She completed her Ph.D. in biologicalsciences at Carnegie Mellon University, where she developed and detailed thefunction of novel fluorescent probes. 

As a postdoctoral fellow at the University ofPittsburgh, she established biosensor-based live-cell screening assays for thedetection of hepatotoxicity, including the use of a human liver“organ-on-a-chip” model. She joined Sartorius in 2019 as a senior scientist.

Yanping is the Flow Cytometry Translational Technology Platform (TTP) manager at the prestigious UCL Cancer Institute. This institute holds an esteemed international reputation for its leadership in diverse realms of cancer research, encompassing fundamental, translational, and clinical dimensions. The Flow Cytometry lab, equipped with the latest equipment, facilitates cutting-edge research that bridges laboratory discoveries to real-world applications.

Yanping gained her D.Phil degree in Clinical Laboratory Sciences from Oxford, backed by a robust background in immunology, haematology, and molecular biology. Her research interests include applying flow and mass cytometry in stem cell and cancer research.

Sarwish Rafiq, PhD is an Assistant Professor in the Department of Hematology and Medical Oncology at the Emory School of Medicine. She is a translational scientist with expertise in the preclinical development of immune-based therapies for cancer. Specifically, Dr. Rafiq’s research aims to use mechanistic insight of immune effector cell function against cancer cells in the tumor microenvironment to inform the development of novel and effective cellular therapies.